All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
OMEGA THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: OMGA

Business Address

140 FIRST STREET, SUITE 501

CAMBRIDGE , MA US 02141

Mailing Address

140 FIRST STREET, SUITE 501

CAMBRIDGE , MA US 02141
Phone Number: (617) 949-4360 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $68,443,000.00 $81,768,000.00 $105,537,000.00 $104,541,000.00 $70,615,000.00 $76,614,000.00 $90,857,000.00 $105,648,000.00 $186,482,000.00 $234,300,000.00 $122,400,000.00 -- $22,951,000.00 $31,728,000.00 $31,887,000.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $10,324,000.00 $12,201,000.00 $10,746,000.00 $11,590,000.00 $12,294,000.00 $12,063,000.00 $8,830,000.00 $5,265,000.00 $3,702,000.00 $4,484,000.00 $1,301,000.00 -- $1,052,000.00 -- -- -- --
Total Current Assets $89,884,000.00 $101,898,000.00 $124,928,000.00 $148,852,000.00 $137,590,000.00 $161,038,000.00 $183,076,000.00 $206,457,000.00 $229,286,000.00 $238,759,000.00 $125,297,000.00 -- $24,003,000.00 -- -- -- --
Property Plant and Equipement $5,311,000.00 $5,356,000.00 $5,530,000.00 $4,208,000.00 $4,195,000.00 $3,889,000.00 $3,958,000.00 $3,936,000.00 $3,605,000.00 $3,785,000.00 $4,100,000.00 -- $3,482,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $94,000.00 $119,000.00 $150,000.00 $182,000.00 $204,000.00 $198,000.00 $146,000.00 $124,000.00 $101,000.00 $386,000.00 $308,000.00 -- $257,000.00 -- -- -- --
Total Assets $204,366,000.00 $217,808,000.00 $229,022,000.00 $156,315,000.00 $145,998,000.00 $170,065,000.00 $193,046,000.00 $217,301,000.00 $233,333,000.00 $243,271,000.00 $130,046,000.00 -- $28,083,000.00 -- -- -- --
Accounts Payable $1,620,000.00 $2,403,000.00 $6,325,000.00 $3,678,000.00 $3,107,000.00 $2,567,000.00 $2,731,000.00 $2,051,000.00 $2,109,000.00 $911,000.00 $1,169,000.00 -- $1,063,000.00 -- -- -- --
Accrued Liabilities $7,914,000.00 $7,518,000.00 $7,199,000.00 $6,857,000.00 $13,841,000.00 $10,342,000.00 $8,959,000.00 $9,003,000.00 $9,475,000.00 $8,711,000.00 $7,268,000.00 -- $3,277,000.00 -- -- -- --
Total Current Liabilities $146,350,000.00 $141,765,000.00 $133,103,000.00 $33,315,000.00 $40,027,000.00 $36,414,000.00 $35,662,000.00 $35,947,000.00 $32,705,000.00 $22,932,000.00 $21,937,000.00 -- $17,486,000.00 -- -- -- --
Long Term Debt $18,885,000.00 $19,864,000.00 $19,956,000.00 $19,945,000.00 $19,936,000.00 $19,901,000.00 $19,892,000.00 $19,880,000.00 $19,869,000.00 $11,985,000.00 $11,806,000.00 -- $11,732,000.00 -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-14,000.00 $-86,000.00 $-171,000.00 $-228,000.00 $-479,000.00 $-917,000.00 $-1,006,000.00 $-859,000.00 $-62,000.00 -- -- -- -- -- -- -- --
Accumulated Deficit $-334,634,000.00 $-314,420,000.00 $-292,172,000.00 $-262,485,000.00 $-237,206,000.00 $-206,380,000.00 $-180,581,000.00 $-154,669,000.00 $-134,505,000.00 $-113,651,000.00 $-95,123,000.00 -- $-66,225,000.00 -- -- -- --
Total Stockholders' Equity $58,016,000.00 $76,043,000.00 $95,919,000.00 $123,000,000.00 $105,971,000.00 $133,651,000.00 $157,384,000.00 $181,354,000.00 $200,628,000.00 $220,339,000.00 $-92,484,000.00 $-77,877,000.00 $-64,628,000.00 $-55,365,000.00 $-47,391,000.00 $-41,185,000.00 $-35,919,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $204,366,000.00 $217,808,000.00 $229,022,000.00 $156,315,000.00 $145,998,000.00 $170,065,000.00 $193,046,000.00 $217,301,000.00 $233,333,000.00 $243,271,000.00 $130,046,000.00 -- $28,083,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues $3,094,000.00 $2,105,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $77,169,000.00 $16,475,000.00 $44,979,000.00 $19,968,000.00 $79,996,000.00 $54,329,000.00 $33,659,000.00 $14,191,000.00 $47,865,000.00 $33,222,000.00 $20,933,000.00 -- -- $13,921,000.00 $8,416,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $103,355,000.00 $81,667,000.00 $31,599,000.00 $26,334,000.00 $104,839,000.00 $26,580,000.00 $26,330,000.00 $20,227,000.00 $66,176,000.00 $45,368,000.00 $28,148,000.00 -- -- $19,403,000.00 $11,358,000.00 -- --
Loss from Operations $-100,261,000.00 $-22,903,000.00 $-56,658,000.00 $-25,818,000.00 $-102,766,000.00 $-25,985,000.00 $-45,814,000.00 $-19,959,000.00 $-66,032,000.00 $-45,368,000.00 $-28,148,000.00 -- -- $-19,403,000.00 $-6,130,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-1.80 $-1.44 $-1.04 $-0.50 $-2.14 $-1.50 $-0.54 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 54,010,996 55,140,058 52,861,655 50,627,287 47,880,819 47,837,490 47,849,639 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.80 $-1.44 $-1.04 $-0.50 $-2.14 $-1.50 $-0.96 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 54,010,996 53,629,468 52,861,655 50,627,287 47,880,819 47,854,965 47,828,594 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 175,000,000 175,000,000 137,700,000 -- -- -- --
Common Stock Shares Outstanding 55,144,982 55,141,838 55,136,908 55,023,089 48,072,517 47,856,561 47,852,508 47,840,045 47,793,469 47,768,565 4,647,035 -- 4,465,351 -- -- -- --
Common Stock Value $55,000.00 $55,000.00 $55,000.00 $55,000.00 $48,000.00 $48,000.00 $48,000.00 $48,000.00 $48,000.00 $48,000.00 $5,000.00 -- $5,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com